Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the American Academy of Child and Adolescent Psychiatry"
DOI: 10.1016/j.jaac.2017.04.005
Abstract: OBJECTIVE Methylphenidate has prominent effects in the dopamine-rich striatum that are absent for the selective norepinephrine transporter inhibitor atomoxetine. This study tested whether baseline striatal activation would predict differential response to the two medications in… read more here.
Keywords: response; responses methylphenidate; methylphenidate atomoxetine; activation ... See more keywords